B

Bering Capital

3 employees

Venture capital firm investing in biopharmaceuticals and medical devices.

Investor insights

Sectors invested in

Biotechnology2
Health Care2
Therapeutics2
Biopharma2

Funding rounds participated in

$15M sweet spot round size

Most of their 3 investments are in rounds between $14M and $15M

Investor type

Venture Capital

Basic info

Industry

venture capital and private equity principals

Sectors

Health Care

Date founded

2020

Investments made

O

OncoResponse Inc. raised $14M on May 18, 2023

Investors: RiverVest Venture Partners, INTERVEST-Mortgage Investment Co., 3B Future Health Fund, Canaan, Takeda UK Limited, ARCH Venture Partners and Bering Capital

O

OncoResponse Inc. raised $41M on March 31, 2021

Investors: 3B Future Health Fund, RiverVest Venture Partners, Redmile Group, ARCH Venture Partners, Magnetar Capital, Qatar Investment Authority, Canaan and Bering Capital

U

Undisclosed raised $15M on May 22, 2020

Investors: Sanderling Ventures, Valence Life Sciences and Bering Capital

FAQ